Yi Luo
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Clinical Biochemistry top 2%
- Advanced Glycation End Products research
Papers in
-
- Cancer, Hypoxia, and Metabolism 14
- Cancer-related molecular mechanisms research 13
- MicroRNA in disease regulation 6
-
- Advanced Glycation End Products research 7
- Co-authors
- Hiroki KuniyasuHitoshi OhmoriKiyomu FujiiTakamitsu SasakiRina Fujiwara‐TaniTomonori SasahiraShingo KishiShiori Mori
In The Last Decade
Yi Luo
72 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 98
- Cancer Research 499
- Clinical Biochemistry 215
- Neurology 143
- Molecular Biology 895
- Oncology 273
Countries citing papers authored by Yi Luo
This map shows the geographic impact of Yi Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Luo more than expected).
Fields of papers citing papers by Yi Luo
This network shows the impact of papers produced by Yi Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Luo. The network helps show where Yi Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 15 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 11 | |
| 7 | 2021 | 13 | |
| 8 | 2020 | 20 | |
| 9 | 2019 | 19 | |
| 10 | 2019 | 29 | |
| 11 | 2019 | 4 | |
| 12 | 2017 | 28 | |
| 13 | 2017 | 48 | |
| 14 | 2016 | 35 | |
| 15 | 2016 | 27 | |
| 16 | 2014 | 122 | |
| 17 | 2013 | 30 | |
| 18 | 2012 | 15 | |
| 19 | 2009 | 13 | |
| 20 | 2009 | 10 |
About Yi Luo
Yi Luo is a scholar working on Cancer Research, Clinical Biochemistry, Neurology, Biotechnology and Molecular Biology, having authored 75 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (14 papers), Cancer-related molecular mechanisms research (13 papers), Barrier Structure and Function Studies (7 papers), Autophagy in Disease and Therapy (7 papers), RNA modifications and cancer (7 papers), Advanced Glycation End Products research (7 papers), MicroRNA in disease regulation (6 papers) and Cancer Research and Treatments (6 papers). The work is most often cited by research in Cancer Research (499 citations), Clinical Biochemistry (215 citations), Neurology (143 citations), Molecular Biology (895 citations) and Oncology (273 citations). Yi Luo has collaborated with scholars based in China, Japan and India. Frequent co-authors include Hiroki Kuniyasu, Hitoshi Ohmori, Kiyomu Fujii, Takamitsu Sasaki, Rina Fujiwara‐Tani, Tomonori Sasahira, Shingo Kishi, Shiori Mori, Yukiko Nishiguchi and Zhenming Hu. Their work appears in journals such as International Journal of Molecular Sciences, Oncotarget, Pathobiology, Cancer Science and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.